Inflammasomes: Pandora's box for sepsis.

Area of Science:

• Immunology
• Pathophysiology
• Molecular Biology

Background:

• Sepsis, a life-threatening condition involving organ dysfunction due to infection, has been recognized since ancient times but its precise mechanisms remain challenging.
• Despite advances, developing targeted therapies for sepsis remains difficult, highlighting the need for deeper understanding of immune dysregulation.
• Recent immunological discoveries include pattern recognition receptors and inflammasomes, which are critical cytosolic sensors of pathogens.

Purpose of the Study:

• To review the role of inflammasomes in sepsis pathogenesis.
• To explore how inflammasomes regulate immune responses in sepsis.
• To discuss the potential of targeting inflammasomes as a novel therapeutic strategy for sepsis.

Main Methods:

• This review synthesizes current knowledge on inflammasome pathways in sepsis.
• It examines the recognition of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) by inflammasomes.
• The review discusses the involvement of inflammasome-mediated cytokine production (IL-1β, IL-18, IL-33) and pyroptosis in sepsis.

Main Results:

• Inflammasome activation, through both canonical and non-canonical pathways, drives pro-inflammatory responses in sepsis.
• Inflammasomes recognize cytosolic pathogens and their PAMPs, contributing significantly to sepsis pathology.
• Cross-talk exists between inflammasomes and other sepsis-related molecules, including DAMPs.

Conclusions:

• Inflammasomes are central players in the immune response during sepsis.
• Their activation leads to the release of key inflammatory cytokines and induces pyroptosis, exacerbating sepsis.
• Targeting inflammasome signaling pathways presents a promising avenue for developing novel sepsis therapeutics.